Technology, Consumer Staples, Healthcare Jul 30, 2021 04:36 PM (GMT+8) · EqualOcean
According to the announcement on the website of the State Drug Administration of the people's Republic of China on the release of information on drug approval documents to be collected on July 30, 2021, the application for approval of the production of rosuvastatin calcium tablets (5mg, 10mg, 20mg) and atorvastatin calcium tablets (10mg, 20mg, 40mg) submitted by the company's joint venture Ningbo kelkang meinovartis Pharmaceutical Co., Ltd. ("kelkang meinovartis") has been completed, The drug approval certificate was issued on July 28, 2021.
Related companies: